Natural supplement combo may match standard drug for prostate relief

NCT ID NCT07665749

Not yet recruiting Symptom relief Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will compare two treatments for moderate to severe urinary symptoms caused by an enlarged prostate. One group takes a standard drug (alfalitic) plus a natural supplement (Serenoa repens, or saw palmetto), while the other takes the same drug plus another standard medication (antimuscarinic). The goal is to see if the natural supplement combo works just as well, with fewer side effects. Fifty men aged 40 to 80 will be followed for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: alfalitic plus Serenoa repens (saw palmetto extract)
What this could lead to: If successful, this could show that a combination with a natural supplement works as well as one with a standard drug, potentially offering a gentler option for managing urinary symptoms.
What could go wrong: This is a small, early-stage study with only 50 participants. It compares existing treatments, not a new breakthrough, so results may not change standard care. Side effects are still possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATE HYPERTROPHY(BPH)

More trials for these conditions

Other studies related to the condition(s) this trial covers.